论文部分内容阅读
目的:了解我院近三年来口服降糖药的应用情况。方法:采用销售金额排序法及DDDs排序法,对我院2006～2008年使用的口服降糖药的用药金额、用药频度等项指标进行统计分析。结果:口服降糖药用药金额逐年上升,格列吡嗪和二甲双胍的用药金额和DDDs排序稳居前三位,阿卡波糖增长迅速,用药金额2008年已跃居第一位。结论:我院临床使用的口服降糖药以磺酰脲类和双胍类为主,葡萄糖苷酶抑制药阿卡波糖发展前景广阔。
Objective: To understand the application of oral hypoglycemic agents in our hospital in the past three years. Methods: Using the method of sorting the sales amount and sorting by DDDs, statistical analysis was made on the dosage of oral hypoglycemic agents used in our hospital from 2006 to 2008 and the frequency of medication. Results: The amount of oral hypoglycemic drugs increased year by year, glipizide and metformin drug amounts and DDDs ranked the top three ranks, acarbose rapid growth, the amount of medication in 2008 has leapt to first place. Conclusion: Oral hypoglycemic agents used clinically in our hospital are mainly sulfonylureas and biguanides. Acarbose, a glucosidase inhibitor, has a promising future.